A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/22 (2006.01) A61K 31/366 (2006.01) A61K 31/40 (2006.01) A61K 31/405 (2006.01) A61K 31/4418 (2006.01) A61K 31/47 (2006.01) A61K 31/506 (2006.01) A61K 45/00 (2006.01) A61P 3/10 (2006.01) A61P 5/50 (2006.01)
Patent
CA 2524175
It is intended to provide a medicinal composition containing an HMG-CoA reductase inhibitor as the active ingredient which aims at: enhancing the ability to intake sugar into warm-blooded animal cells; treating diabetes; treating or preventing diabetic complications; treating or preventing diabetes or diabetic complications caused by insulin resistance syndrome, and so on.
L'invention concerne une composition médicinale contenant un inhibiteur de l'HMG-CoA réductase comme principe actif, laquelle composition vise à : activer l'aptitude à consommer du sucre dans des cellules d'animaux à sang chaud, traiter le diabète, traiter ou prévenir les complications diabétiques, traiter ou prévenir le diabète ou les complications diabétiques causés par le syndrome d'insulinorésistance, etc.
Shimomura Iichiro
Takagi Toshiyuki
Marks & Clerk
Sankyo Company Limited
Shimomura Iichiro
LandOfFree
Sugar intake-ability enhancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sugar intake-ability enhancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sugar intake-ability enhancer will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1938108